Exact Mass: 576.4191752

Exact Mass Matches: 576.4191752

Found 500 metabolites which its exact mass value is equals to given mass value 576.4191752, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

beta-Sitosterol 3-O-beta-D-galactopyranoside

(2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C35H60O6 (576.4389659999999)


Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. beta-Sitosterol 3-O-beta-D-galactopyranoside is found in herbs and spices. beta-Sitosterol 3-O-beta-D-galactopyranoside is a constituent of Hibiscus sabdariffa (roselle) leaves. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

3-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178376)


3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial). [HMDB] 3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid is an intermediate in the biosynthesis of Ubiquinone. It is a substrate for Hexaprenyldihydroxybenzoate methyltransferase (mitochondrial).

   

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone

4-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-hydroxy-6-methoxy-3-methylcyclohexa-3,5-diene-1,2-dione

C38H56O4 (576.4178376)


2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114]. [HMDB] 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is involved in the ubiquinone biosynthesis pathway. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is created from 2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone by ubiquinone biosynthesis monooxygenase Coq7 [EC:1.14.13.-]. 2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone is then converted to ubiquinone by hexaprenyldihydroxybenzoate methyltransferase [EC:2.1.1.114].

   

Campesteryl ferulate

[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


Campesteryl ferulate is found in cereals and cereal products. Campesteryl ferulate is a constituent of various cereal grains Constituent of various cereal grains

   

Schottenol 3-glucoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


Constituent of citron-melon fruits (Citrullus lanatus variety citroides). Schottenol 3-glucoside is found in watermelon, fruits, and spinach. Schottenol 3-glucoside is found in fruits. Schottenol 3-glucoside is a constituent of citron-melon fruits (Citrullus lanatus var. citroides).

   

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl dodecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

(2S)-3-(dodecanoyloxy)-2-hydroxypropyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-(Dodecanoyloxy)-3-hydroxypropan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

(2S)-2-(Dodecanoyloxy)-3-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

(2S)-3-(Dodecanoyloxy)-2-hydroxypropyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

(2S)-3-Hydroxy-2-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

(2R)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-{3-[(5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-{3-[(5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

(2R)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoyl]oxy}propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

(2S)-3-Hydroxy-2-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

(2S)-1-Hydroxy-3-[(4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propan-2-yl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

(2R)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(4-{3-[(2Z,5Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoyl)oxy]propyl 10-methylundecanoic acid

C35H60O6 (576.4389659999999)


DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5R,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5S,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,19S)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,18R)-18-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

(2S)-1-hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16R)-16-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

(2S)-3-hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5Z,8Z,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

(2S)-2-hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C35H60O6 (576.4389659999999)


DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5E,8Z,11R,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

(2S)-1-Hydroxy-3-[(10-methylundecanoyl)oxy]propan-2-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

(2S)-3-Hydroxy-2-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

(2R)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

(2S)-2-Hydroxy-3-[(10-methylundecanoyl)oxy]propyl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoic acid

C35H60O6 (576.4389659999999)


DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

24-Methylcholesterol ferulate

(2R,5S,14R,15R)-14-[(2R)-5,6-dimethylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


24-methylcholesterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylcholesterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylcholesterol ferulate can be found in corn, which makes 24-methylcholesterol ferulate a potential biomarker for the consumption of this food product.

   

24-Methyllathosterol ferulate

(2S,5S,7S,14R,15R)-14-[(2R)-5,6-dimethylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


24-methyllathosterol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methyllathosterol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methyllathosterol ferulate can be found in corn, which makes 24-methyllathosterol ferulate a potential biomarker for the consumption of this food product.

   

24-Methylenecholestanol ferulate

(2S,5S,7S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methyl-5-methylideneheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


24-methylenecholestanol ferulate is a member of the class of compounds known as steroid esters. Steroid esters are compounds containing a steroid moiety which bears a carboxylic acid ester group. 24-methylenecholestanol ferulate is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 24-methylenecholestanol ferulate can be found in corn, which makes 24-methylenecholestanol ferulate a potential biomarker for the consumption of this food product.

   

Coriandrinol

(2R,3R,4S,5S,6R)-2-{[(1S,2R,10S,11S,15R)-14-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


Coriandrinol belongs to stigmastanes and derivatives class of compounds. Those are sterol lipids with a structure based on the stigmastane skeleton, which consists of a cholestane moiety bearing an ethyl group at the carbon atom C24. Coriandrinol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Coriandrinol can be found in coriander, which makes coriandrinol a potential biomarker for the consumption of this food product. Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

Bacosterol-3-O-beta-D-glucopyranoside

Bacosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.4389659999999)


   

1,3-Diacetyl-24-epi-polacandrin

1,3-Diacetyl-24-epi-polacandrin

C34H56O7 (576.4025826)


   
   

3alpha-acetoxy-21S,25-dimethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin F

3alpha-acetoxy-21S,25-dimethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S-diol|chisopanin F

C34H56O7 (576.4025826)


   

3alpha-acetoxy-21R-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S,25-triol|chisopanin G

3alpha-acetoxy-21R-ethoxy-17alpha-20S-21,23R-epoxyapotirucall-14-ene-7alpha,24S,25-triol|chisopanin G

C34H56O7 (576.4025826)


   

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

beta-sitosterol-delta-glucopyranoside|beta-sitosteryl-beta-D-glucoside|sitosterol-beta-D-glucoside

C35H60O6 (576.4389659999999)


   

sitosterol-3beta-glucopyranoside

sitosterol-3beta-glucopyranoside

C35H60O6 (576.4389659999999)


   
   

3alpha-hydroxy-28beta-methoxy-13alpha-ursan-28,12beta-epoxide 3-benzoate

3alpha-hydroxy-28beta-methoxy-13alpha-ursan-28,12beta-epoxide 3-benzoate

C38H56O4 (576.4178376)


   
   
   

beta-sitosterol beta-D-glucopyranoside

beta-sitosterol beta-D-glucopyranoside

C35H60O6 (576.4389659999999)


   

(24R)-ergost-5-en-11-oxo-3beta-ol-alpha-D-glucopyranoside|argyroside

(24R)-ergost-5-en-11-oxo-3beta-ol-alpha-D-glucopyranoside|argyroside

C34H56O7 (576.4025826)


   

4-O-acetyl-3-O-[beta-D-arabinopyranosyloxy]-cholest-5-ene-3beta,19-diol

4-O-acetyl-3-O-[beta-D-arabinopyranosyloxy]-cholest-5-ene-3beta,19-diol

C34H56O7 (576.4025826)


   

beta-sitosterol-3-O-beta-D-glucopyranoside

beta-sitosterol-3-O-beta-D-glucopyranoside

C35H60O6 (576.4389659999999)


   

beta-sitosterol-3-O-beta-D-glucoside

beta-sitosterol-3-O-beta-D-glucoside

C35H60O6 (576.4389659999999)


   
   

Daucosterol

(2R,3R,4S,5S,6R)-2-(((3S,8S,9S,10R,13R,14S,17R)-17-((2R,5R)-5-Ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

C35H60O6 (576.4389659999999)


Daucosterol is a steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. It has a role as a plant metabolite. It is a steroid saponin, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a sitosterol. It derives from a hydride of a stigmastane. Sitogluside is a natural product found in Ophiopogon intermedius, Ophiopogon jaburan, and other organisms with data available. A steroid saponin that is sitosterol attached to a beta-D-glucopyranosyl residue at position 3 via a glycosidic linkage. It has bee isolated from Panax japonicus var. major and Breynia fruticosa. C308 - Immunotherapeutic Agent Daucosterol is a natural sterol compound. Daucosterol is a natural sterol compound.

   

21,24-diacetoxylanostan-3,22,25-triol|terresterol

21,24-diacetoxylanostan-3,22,25-triol|terresterol

C34H56O7 (576.4025826)


   

3beta-O-(alpha-L-fucopyranosyl)-11-hydroxy-24-methylene-9,11-secocholest-5-en-9-one|sinularoside A

3beta-O-(alpha-L-fucopyranosyl)-11-hydroxy-24-methylene-9,11-secocholest-5-en-9-one|sinularoside A

C34H56O7 (576.4025826)


   

10,10-Methylenebis(norvallesamidine)

10,10-Methylenebis(norvallesamidine)

C39H52N4 (576.4191752)


   

beta-sitosterol-beta-D-glucoside

beta-sitosterol-beta-D-glucoside

C35H60O6 (576.4389659999999)


   
   

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

beta-sitosterol-beta-D-glucoside|stigmast-6-en-3-O-beta-(D-glucopyranoside)

C35H60O6 (576.4389659999999)


   

24-methylenecholest-5-en-3beta,7beta,16beta-triol-3-O-alpha-L-fucoside|24-methylenecholest-5-ene-3beta,7beta,16beta-triol-3-O-alpha-L-fucopyranoside

24-methylenecholest-5-en-3beta,7beta,16beta-triol-3-O-alpha-L-fucoside|24-methylenecholest-5-ene-3beta,7beta,16beta-triol-3-O-alpha-L-fucopyranoside

C34H56O7 (576.4025826)


   

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

geniculatoside F|stigmast-16-en-3alpha-O-(beta-D-galactopyranoside)

C35H60O6 (576.4389659999999)


   
   

24-methylenecholestanol ferulate

24-methylenecholestanol ferulate

C38H56O4 (576.4178376)


   

(24R,S)-24-methyllathosterol ferulate

(24R,S)-24-methyllathosterol ferulate

C38H56O4 (576.4178376)


   

PA(P-16:0/12:0)

1-(1Z-hexadecenyl)-2-dodecanoyl-glycero-3-phosphate

C31H61O7P (576.4154685999999)


   

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

stigmast-5-en-3beta-ol 3-0-beta-D-glucopyranoside

C35H60O6 (576.4389659999999)


   

beta-Sitosterol 3-O-beta-D-galactopyranoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

Schottenol glucoside

2-{[14-(5-ethyl-6-methylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

Campesteryl ferulate

14-(5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


   

PA O-28:1

1-(1Z-hexadecenyl)-2-dodecanoyl-glycero-3-phosphate

C31H61O7P (576.4154685999999)


   

glucoclionasterol

poriferast-5-en-3beta-yl beta-D-glucopyranoside

C35H60O6 (576.4389659999999)


   

ST 29:1;O;Hex

stigmast-5-en-3beta-yl beta-D-galactopyranoside

C35H60O6 (576.4389659999999)


   

Oryzanol

campest-5-en-3beta-yl ferulate

C38H56O4 (576.4178376)


   

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid

C38H56O4 (576.4178376)


   
   

Sitosterol glucoside

3-O-(beta-D-glucopyranosyl)-stigmast-5-en-3beta-ol

C35H60O6 (576.4389659999999)


   

24-Methyllathosterol ferulate

24-Methyllathosterol ferulate

C38H56O4 (576.4178376)


   

[(3S,10R,13R,17R)-17-[(2R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(3S,10R,13R,17R)-17-[(2R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


   

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.4389659999999)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.4389659999999)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

DG(i-12:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

DG(i-12:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

DG(i-12:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

DG(i-12:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

DG(i-12:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

DG(i-12:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C35H60O6 (576.4389659999999)


   

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

DG(i-12:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

DG(i-12:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C35H60O6 (576.4389659999999)


   

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

DG(i-12:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

DG(i-12:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C35H60O6 (576.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

DG(i-12:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

DG(i-12:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

DG(i-12:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

DG(i-12:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

DG(i-12:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

DG(i-12:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C35H60O6 (576.4389659999999)


   

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

DG(i-12:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/i-12:0/0:0)

C35H60O6 (576.4389659999999)


   

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

DG(i-12:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C35H60O6 (576.4389659999999)


   

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/i-12:0)

C35H60O6 (576.4389659999999)


   

2-[[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

C35 phosphodolichol

C35 phosphodolichol

C35H61O4P (576.4307236)


   

Mgdg O-19:0_3:0

Mgdg O-19:0_3:0

C31H60O9 (576.423711)


   

Mgdg O-9:0_13:0

Mgdg O-9:0_13:0

C31H60O9 (576.423711)


   

Mgdg O-14:0_8:0

Mgdg O-14:0_8:0

C31H60O9 (576.423711)


   

Mgdg O-18:0_4:0

Mgdg O-18:0_4:0

C31H60O9 (576.423711)


   

Mgdg O-8:0_14:0

Mgdg O-8:0_14:0

C31H60O9 (576.423711)


   

Mgdg O-13:0_9:0

Mgdg O-13:0_9:0

C31H60O9 (576.423711)


   

Mgdg O-16:0_6:0

Mgdg O-16:0_6:0

C31H60O9 (576.423711)


   

Mgdg O-17:0_5:0

Mgdg O-17:0_5:0

C31H60O9 (576.423711)


   

Mgdg O-20:0_2:0

Mgdg O-20:0_2:0

C31H60O9 (576.423711)


   

Mgdg O-15:0_7:0

Mgdg O-15:0_7:0

C31H60O9 (576.423711)


   

Mgdg O-12:0_10:0

Mgdg O-12:0_10:0

C31H60O9 (576.423711)


   

Mgdg O-11:0_11:0

Mgdg O-11:0_11:0

C31H60O9 (576.423711)


   

Mgdg O-10:0_12:0

Mgdg O-10:0_12:0

C31H60O9 (576.423711)


   
   
   
   
   
   
   
   
   
   

[(E)-2-acetamido-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-acetamido-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(butanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(butanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(nonanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(nonanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(hexadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexadecanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(heptadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptadecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(pentanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentanoylamino)icos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(hexanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(hexanoylamino)-3-hydroxynonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(heptanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(heptanoylamino)-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(octanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(octanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(propanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(propanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(decanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(decanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-2-(dodecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-2-(dodecanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

2,3-di(octanoyloxy)propyl (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

2,3-di(octanoyloxy)propyl (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H60O6 (576.4389659999999)


   
   
   
   

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

N-(decanoyl)-4E-pentadecasphingenine-1-phosphocholine

N-(decanoyl)-4E-pentadecasphingenine-1-phosphocholine

C30H61N2O6P (576.4267015999999)


   

[(E,2S,3R)-2-(decanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

[(E,2S,3R)-2-(decanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C30H61N2O6P (576.4267015999999)


   

[1-carboxy-3-[2-hydroxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-hydroxy-3-[(6E,9E,12E,15E,18E)-tetracosa-6,9,12,15,18-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C34H58NO6+ (576.4263908)


   

2-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-[(13E,16E)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

2-[[2-butanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-butanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

2-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

2-[[2-acetyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-acetyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C30H59NO7P+ (576.4028934)


   

3-demethylubiquinone-6

2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone

C38H56O4 (576.4178376)


A polyprenylbenzoquinone that is fumigatin which is substituted by an all-trans-hexaprenyl group at position 6.

   
   

C35-phosphodolichol

C35-phosphodolichol

C35H61O4P (576.4307236)


A dolichyl phosphate in which the dolichyl moiety contains six prenyl units

   

TG(32:3)

TG(16:0_6:0_10:3)

C35H60O6 (576.4389659999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

FAHFA 12:2/O-26:7

FAHFA 12:2/O-26:7

C38H56O4 (576.4178376)


   

FAHFA 12:3/O-26:6

FAHFA 12:3/O-26:6

C38H56O4 (576.4178376)


   

FAHFA 12:4/O-26:5

FAHFA 12:4/O-26:5

C38H56O4 (576.4178376)


   

FAHFA 13:2/O-25:7

FAHFA 13:2/O-25:7

C38H56O4 (576.4178376)


   

FAHFA 13:3/O-25:6

FAHFA 13:3/O-25:6

C38H56O4 (576.4178376)


   

FAHFA 13:4/O-25:5

FAHFA 13:4/O-25:5

C38H56O4 (576.4178376)


   

FAHFA 14:2/O-24:7

FAHFA 14:2/O-24:7

C38H56O4 (576.4178376)


   

FAHFA 14:3/O-24:6

FAHFA 14:3/O-24:6

C38H56O4 (576.4178376)


   

FAHFA 14:4/O-24:5

FAHFA 14:4/O-24:5

C38H56O4 (576.4178376)


   

FAHFA 15:2/O-23:7

FAHFA 15:2/O-23:7

C38H56O4 (576.4178376)


   

FAHFA 15:3/O-23:6

FAHFA 15:3/O-23:6

C38H56O4 (576.4178376)


   

FAHFA 15:4/O-23:5

FAHFA 15:4/O-23:5

C38H56O4 (576.4178376)


   

FAHFA 15:5/O-23:4

FAHFA 15:5/O-23:4

C38H56O4 (576.4178376)


   

FAHFA 16:2/O-22:7

FAHFA 16:2/O-22:7

C38H56O4 (576.4178376)


   

FAHFA 16:3/O-22:6

FAHFA 16:3/O-22:6

C38H56O4 (576.4178376)


   

FAHFA 16:4/O-22:5

FAHFA 16:4/O-22:5

C38H56O4 (576.4178376)


   

FAHFA 16:5/O-22:4

FAHFA 16:5/O-22:4

C38H56O4 (576.4178376)


   

FAHFA 17:2/O-21:7

FAHFA 17:2/O-21:7

C38H56O4 (576.4178376)


   

FAHFA 17:3/O-21:6

FAHFA 17:3/O-21:6

C38H56O4 (576.4178376)


   

FAHFA 17:4/O-21:5

FAHFA 17:4/O-21:5

C38H56O4 (576.4178376)


   

FAHFA 17:5/O-21:4

FAHFA 17:5/O-21:4

C38H56O4 (576.4178376)


   

FAHFA 18:3/O-20:6

FAHFA 18:3/O-20:6

C38H56O4 (576.4178376)


   

FAHFA 18:4/O-20:5

FAHFA 18:4/O-20:5

C38H56O4 (576.4178376)


   

FAHFA 18:5/O-20:4

FAHFA 18:5/O-20:4

C38H56O4 (576.4178376)


   

FAHFA 18:6/O-20:3

FAHFA 18:6/O-20:3

C38H56O4 (576.4178376)


   

FAHFA 19:3/O-19:6

FAHFA 19:3/O-19:6

C38H56O4 (576.4178376)


   

FAHFA 19:4/O-19:5

FAHFA 19:4/O-19:5

C38H56O4 (576.4178376)


   

FAHFA 19:5/O-19:4

FAHFA 19:5/O-19:4

C38H56O4 (576.4178376)


   

FAHFA 19:6/O-19:3

FAHFA 19:6/O-19:3

C38H56O4 (576.4178376)


   

FAHFA 20:3/O-18:6

FAHFA 20:3/O-18:6

C38H56O4 (576.4178376)


   

FAHFA 20:4/O-18:5

FAHFA 20:4/O-18:5

C38H56O4 (576.4178376)


   

FAHFA 20:5/O-18:4

FAHFA 20:5/O-18:4

C38H56O4 (576.4178376)


   

FAHFA 20:6/O-18:3

FAHFA 20:6/O-18:3

C38H56O4 (576.4178376)


   

FAHFA 21:4/O-17:5

FAHFA 21:4/O-17:5

C38H56O4 (576.4178376)


   

FAHFA 21:5/O-17:4

FAHFA 21:5/O-17:4

C38H56O4 (576.4178376)


   

FAHFA 21:6/O-17:3

FAHFA 21:6/O-17:3

C38H56O4 (576.4178376)


   

FAHFA 21:7/O-17:2

FAHFA 21:7/O-17:2

C38H56O4 (576.4178376)


   

FAHFA 22:4/O-16:5

FAHFA 22:4/O-16:5

C38H56O4 (576.4178376)


   

FAHFA 22:5/O-16:4

FAHFA 22:5/O-16:4

C38H56O4 (576.4178376)


   

FAHFA 22:6/O-16:3

FAHFA 22:6/O-16:3

C38H56O4 (576.4178376)


   

FAHFA 22:7/O-16:2

FAHFA 22:7/O-16:2

C38H56O4 (576.4178376)


   

FAHFA 23:4/O-15:5

FAHFA 23:4/O-15:5

C38H56O4 (576.4178376)


   

FAHFA 23:5/O-15:4

FAHFA 23:5/O-15:4

C38H56O4 (576.4178376)


   

FAHFA 23:6/O-15:3

FAHFA 23:6/O-15:3

C38H56O4 (576.4178376)


   

FAHFA 23:7/O-15:2

FAHFA 23:7/O-15:2

C38H56O4 (576.4178376)


   

FAHFA 24:5/O-14:4

FAHFA 24:5/O-14:4

C38H56O4 (576.4178376)


   

FAHFA 24:6/O-14:3

FAHFA 24:6/O-14:3

C38H56O4 (576.4178376)


   

FAHFA 24:7/O-14:2

FAHFA 24:7/O-14:2

C38H56O4 (576.4178376)


   

FAHFA 25:5/O-13:4

FAHFA 25:5/O-13:4

C38H56O4 (576.4178376)


   

FAHFA 25:6/O-13:3

FAHFA 25:6/O-13:3

C38H56O4 (576.4178376)


   

FAHFA 25:7/O-13:2

FAHFA 25:7/O-13:2

C38H56O4 (576.4178376)


   

FAHFA 26:5/O-12:4

FAHFA 26:5/O-12:4

C38H56O4 (576.4178376)


   

FAHFA 26:6/O-12:3

FAHFA 26:6/O-12:3

C38H56O4 (576.4178376)


   

FAHFA 26:7/O-12:2

FAHFA 26:7/O-12:2

C38H56O4 (576.4178376)


   
   
   
   
   
   
   
   
   

PA P-14:0/14:0 or PA O-14:1/14:0

PA P-14:0/14:0 or PA O-14:1/14:0

C31H61O7P (576.4154685999999)


   
   

PA P-16:0/12:0 or PA O-16:1/12:0

PA P-16:0/12:0 or PA O-16:1/12:0

C31H61O7P (576.4154685999999)


   
   

PA P-18:0/10:0 or PA O-18:1/10:0

PA P-18:0/10:0 or PA O-18:1/10:0

C31H61O7P (576.4154685999999)


   
   
   

Hexaprenylmethylhydroxymethoxybenzoquinone

Hexaprenylmethylhydroxymethoxybenzoquinone

C38H56O4 (576.4178376)


   
   
   
   
   
   
   
   
   
   
   
   

(4r,6r)-4-hydroxy-6-[(1e,4r,5e,8r,9e,11s,12r,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-[(2r,4s,6s)-2,4,6-trimethyloctylidene]hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

(4r,6r)-4-hydroxy-6-[(1e,4r,5e,8r,9e,11s,12r,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-[(2r,4s,6s)-2,4,6-trimethyloctylidene]hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4025826)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

7-(acetyloxy)-11-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

7-(acetyloxy)-11-hydroxy-1-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4025826)


   

4-hydroxy-6-[(1e,5e,9e,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

4-hydroxy-6-[(1e,5e,9e,13e,15z)-4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5r,6r)-4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C35H60O6 (576.4389659999999)


   

(2s,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2s,3s,4r,5r,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3s,4r,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4r,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

[(1s,4r,12r,16s,17s)-17-hydroxy-12-methyl-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5(9),6,10-trien-17-yl]methyl (9z,12z)-octadeca-9,12-dienoate

[(1s,4r,12r,16s,17s)-17-hydroxy-12-methyl-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5(9),6,10-trien-17-yl]methyl (9z,12z)-octadeca-9,12-dienoate

C38H56O4 (576.4178376)


   

6′-palmitoxyl-β-daucosterin

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN012746","Ingredient_name": "6\u2032-palmitoxyl-\u03b2-daucosterin","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33331","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

aucosterol

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN017340","Ingredient_name": "aucosterol","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33332","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

bacosterol-3-o-β-d-glucopyranoside

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN017504","Ingredient_name": "bacosterol-3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CC=CC2CCC3CC(CCC3(C2=CCC1C)C)OC4C(C(C(C(O4)CO)O)O)O)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2095","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-daucosterin

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018050","Ingredient_name": "\u03b2-daucosterin","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35374","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-daucostero

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018051","Ingredient_name": "\u03b2-daucostero","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39817","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-dauosterol

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018054","Ingredient_name": "\u03b2-dauosterol","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36019","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

β-sitosterol-3-o-β-d-glucoside

β-sitosterol-3-o-β-d-gluco-side; beta-sitosterol-3-o-beta-d-gluco-side; beta-sitosterol-3-o-beta-d-glucoside

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018290","Ingredient_name": "\u03b2-sitosterol-3-o-\u03b2-d-glucoside","Alias": "\u03b2-sitosterol-3-o-\u03b2-d-gluco-side; beta-sitosterol-3-o-beta-d-gluco-side; beta-sitosterol-3-o-beta-d-glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT01935","TCMID_id": "19969;23905;25113","TCMSP_id": "NA","TCM_ID_id": "10347;10348;6243","PubChem_id": "12309073","DrugBank_id": "NA"}

   

β-sitosterol-α-d-glucoside

NA

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018296","Ingredient_name": "\u03b2-sitosterol-\u03b1-d-glucoside","Alias": "NA","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19970","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

beta-Sitosterol-alpha-glucoside

beta-sitosterol-alpha-glucoside; β-sitosterol-α- glucoside

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018297","Ingredient_name": "beta-Sitosterol-alpha-glucoside","Alias": "beta-sitosterol-alpha-glucoside; \u03b2-sitosterol-\u03b1- glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.95","OB_score": "20.63193686","CAS_id": "NA","SymMap_id": "SMIT01014","TCMID_id": "25282;34477","TCMSP_id": "MOL001770","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

beta-sitosterol-beta-d-glucoside

β- sitosterol-β-D- glucoside; β-sitosterol-β-D-glucoside; β-sitosterol-β-d-glucoside; β-sitosterol- β- D- glucoside

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018301","Ingredient_name": "beta-sitosterol-beta-d-glucoside","Alias": "\u03b2- sitosterol-\u03b2-D- glucoside; \u03b2-sitosterol-\u03b2-D-glucoside; \u03b2-sitosterol-\u03b2-d-glucoside; \u03b2-sitosterol- \u03b2- D- glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "19.57852635","CAS_id": "NA","SymMap_id": "SMIT08823;SMIT17727","TCMID_id": "25281;41224;35764;19971;38323","TCMSP_id": "MOL007375","TCM_ID_id": "17880","PubChem_id": "91884650","DrugBank_id": "NA"}

   

β-sitosterol- D- glucoside

beta-sitosterol-d-glucoside

C35H60O6 (576.4389659999999)


{"Ingredient_id": "HBIN018304","Ingredient_name": "\u03b2-sitosterol- D- glucoside","Alias": "beta-sitosterol-d-glucoside","Ingredient_formula": "C35H60O6","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C","Ingredient_weight": "576.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35368","TCMSP_id": "NA","TCM_ID_id": "19707;21899","PubChem_id": "12309060","DrugBank_id": "NA"}

   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7r,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7r,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4as,6as,10r,11s,13bs)-10-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

2-{[10-(5-ethyl-6-methylheptan-2-yl)-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[10-(5-ethyl-6-methylheptan-2-yl)-11,13b-dimethyl-1h,2h,3h,4h,4ah,5h,6h,6ah,9h,10h,11h,12h-cyclonona[a]naphthalen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

6-{[9a-(hydroxymethyl)-11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

6-{[9a-(hydroxymethyl)-11a-methyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4025826)


   

[7-(acetyloxy)-8,9-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

[7-(acetyloxy)-8,9-dihydroxy-1-(6-hydroxy-6-methylhept-4-en-2-yl)-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

4-hydroxy-6-[4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

4-hydroxy-6-[4,8,12,16-tetrahydroxy-11,13-dimethyl-15-(2,4,6-trimethyloctylidene)hexadeca-1,5,9,13-tetraen-1-yl]oxan-2-one

C34H56O7 (576.4025826)


   

(1s,4r,5r,8r,10r,13r,14r,16r,17s,18s,19s,20r,23r)-23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

(1s,4r,5r,8r,10r,13r,14r,16r,17s,18s,19s,20r,23r)-23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C38H56O4 (576.4178376)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3br,7s,9as,9br,11ar)-1-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-3a,11a-dimethyl-1h,2h,3h,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(3r,5ar,6r,7s,9ar)-6-{2-[(3r,5ar,6s,9ar)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

(3r,5ar,6r,7s,9ar)-6-{2-[(3r,5ar,6s,9ar)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4025826)


   

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(3r,5r,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-(acetyloxy)-2,5-dihydroxy-2-methylheptan-3-yl acetate

(3r,5r,6r)-6-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-(acetyloxy)-2,5-dihydroxy-2-methylheptan-3-yl acetate

C34H56O7 (576.4025826)


   

(3s,5as,6s,7r,9as)-6-{2-[(3s,5as,6r,9as)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

(3s,5as,6s,7r,9as)-6-{2-[(3s,5as,6r,9as)-3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl]ethyl}-3-(acetyloxy)-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4025826)


   

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

1-[5-(1,2-dihydroxy-2-methylpropyl)-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methoxyoxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4025826)


   

(1r,3as,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

(1r,3as,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C38H56O4 (576.4178376)


   

4-hydroxy-1-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

4-hydroxy-1-[5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,11h-cyclopenta[a]phenanthren-10-one

C34H56O7 (576.4025826)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2r,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-3b,9a-dimethyl-1h,2h,3h,3ah,4h,6h,7h,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-1-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-ethoxyoxolan-3-yl]-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

23-methoxy-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[14.6.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosan-10-yl benzoate

C38H56O4 (576.4178376)


   

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2s,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

[(1r,3ar,3br,5ar,6r,7r,8r,9r,9ar,9bs,11ar)-7-(acetyloxy)-8,9-dihydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

[(1r,3ar,3br,5ar,6r,7r,8r,9r,9ar,9bs,11ar)-7-(acetyloxy)-8,9-dihydroxy-1-[(2r,4e)-6-hydroxy-6-methylhept-4-en-2-yl]-3a,3b,6,9a-tetramethyl-dodecahydro-1h-cyclopenta[a]phenanthren-6-yl]methyl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3ar,5as,7s,9as,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4r,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4r,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1s,3as,3bs,7s,9ar,9br,11as)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5r,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,3br,4r,5ar,7r,9as,9br,11as)-4-hydroxy-1-[(2s,3s,5r)-5-[(1s)-1-hydroxy-2-methoxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C34H56O7 (576.4025826)


   

3-(acetyloxy)-6-[2-(3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

3-(acetyloxy)-6-[2-(3-hydroxy-2,2,5a-trimethyl-7-methylidene-hexahydro-3h-1-benzoxepin-6-yl)ethyl]-2,2,5a,7-tetramethyl-hexahydro-3h-1-benzoxepin-7-yl acetate

C34H56O7 (576.4025826)


   

(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-7-(acetyloxy)-11-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

(1s,3ar,3br,5as,7r,9r,9ar,9bs,11r,11ar)-7-(acetyloxy)-11-hydroxy-1-[(2s,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-9-yl acetate

C34H56O7 (576.4025826)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,5ar,7s,9as,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(3as,3bs,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3as,3bs,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-hydroxy-6-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione

2-[(2e,6e,10e,14e,18e)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5-hydroxy-6-methoxy-3-methylcyclohexa-2,5-diene-1,4-dione

C38H56O4 (576.4178376)


   

(3e,5e,11e,13e)-16-[4-(6-ethyl-2-hydroxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

(3e,5e,11e,13e)-16-[4-(6-ethyl-2-hydroxy-5-methyloxan-2-yl)-3-hydroxypentan-2-yl]-8-hydroxy-15-methoxy-3,5,7,9,11-pentamethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one

C34H56O7 (576.4025826)


   

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

7-(acetyloxy)-2,5-dihydroxy-6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate

7-(acetyloxy)-2,5-dihydroxy-6-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate

C34H56O7 (576.4025826)


   

(2r,3s,4s,5s,6s)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3s,4s,5s,6s)-2-{[(1r,3ar,3br,7s,9ar,9br,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H60O6 (576.4389659999999)


   

(3r,4s,5s,6s)-6-{[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

(3r,4s,5s,6s)-6-{[(1r,3as,3bs,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C34H56O7 (576.4025826)